Pacira Biosciences Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
40.32USD
24 Apr 2019
40.32USD
24 Apr 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$40.32
$40.32
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
171,808
171,808
52-wk High
$54.92
$54.92
52-wk Low
$30.00
$30.00
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.34 | December | 25 Apr 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 5 | 5 | 5 | 5 |
| (3) HOLD | 6 | 6 | 7 | 8 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.60 | 2.60 | 2.62 | 2.56 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 15 | 98.41 | 102.00 | 94.70 | 87.20 |
| Quarter Ending Sep-19 | 15 | 101.50 | 105.60 | 98.79 | 88.90 |
| Year Ending Dec-19 | 15 | 404.05 | 417.50 | 389.19 | 364.46 |
| Year Ending Dec-20 | 15 | 445.30 | 479.34 | 375.74 | 414.15 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 14 | 0.34 | 0.46 | 0.22 | 0.17 |
| Quarter Ending Sep-19 | 14 | 0.37 | 0.48 | 0.24 | 0.17 |
| Year Ending Dec-19 | 14 | 1.49 | 1.80 | 1.06 | 1.09 |
| Year Ending Dec-20 | 14 | 2.11 | 2.85 | 1.13 | 1.84 |
| LT Growth Rate (%) | 1 | 56.10 | 56.10 | 56.10 | 62.25 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-18 | 93.69 | 95.11 | 1.42 | 1.52 |
| Quarter Ending Sep-18 | 80.18 | 83.45 | 3.26 | 4.07 |
| Quarter Ending Jun-18 | 79.13 | 81.11 | 1.98 | 2.50 |
| Quarter Ending Mar-18 | 73.83 | 74.61 | 0.77 | 1.05 |
| Quarter Ending Dec-17 | 79.32 | 79.08 | 0.24 | 0.31 |
| Earnings (per share) | ||||
| Quarter Ending Dec-18 | 0.28 | 0.47 | 0.19 | 70.72 |
| Quarter Ending Sep-18 | 0.08 | 0.31 | 0.23 | 284.14 |
| Quarter Ending Jun-18 | 0.07 | 0.24 | 0.17 | 226.53 |
| Quarter Ending Mar-18 | 0.02 | 0.02 | 0.00 | 16.32 |
| Quarter Ending Dec-17 | 0.10 | 0.38 | 0.28 | 297.49 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 98.41 | 98.37 | 98.37 | 93.25 | 87.20 |
| Quarter Ending Sep-19 | 101.50 | 101.30 | 101.30 | 93.13 | 88.90 |
| Year Ending Dec-19 | 404.05 | 403.83 | 403.83 | 384.06 | 364.46 |
| Year Ending Dec-20 | 445.30 | 444.91 | 444.91 | 428.87 | 414.15 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 0.34 | 0.34 | 0.34 | 0.28 | 0.17 |
| Quarter Ending Sep-19 | 0.37 | 0.37 | 0.37 | 0.29 | 0.17 |
| Year Ending Dec-19 | 1.49 | 1.49 | 1.49 | 1.38 | 1.09 |
| Year Ending Dec-20 | 2.11 | 2.10 | 2.10 | 2.01 | 1.84 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-19 | 1 | 1 | 1 | 1 |
| Quarter Ending Sep-19 | 2 | 0 | 2 | 0 |
| Year Ending Dec-19 | 1 | 0 | 1 | 0 |
| Year Ending Dec-20 | 1 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Jun-19 | 1 | 1 | 1 | 1 |
| Quarter Ending Sep-19 | 2 | 0 | 2 | 0 |
| Year Ending Dec-19 | 1 | 0 | 2 | 0 |
| Year Ending Dec-20 | 1 | 0 | 1 | 0 |
Earnings vs. 
Estimates